On-Q-ity founder Aspinall joins Ventana; Wright Medical discusses Q2 results;

> Roche's Ventana Medical Systems has announced the appointment of Mara Aspinall to the role of president. Aspinall was most recently president and CEO of On-Q-ity, a diagnostics company focused on circulating tumor cell technology. Roche release

> Wright Medical saw net sales of $132.5 million during the second quarter, representing a 4% increase over net sales of $127.7 million during the same period last year. Wright Medical release

> SeraCare Life Sciences' board of directors is evaluating potential alternatives for the company to enhance shareholder value, including a sale or other transaction. SeraCare release

> Toshiba America Medical Systems has tapped Scott Goodwin as VP of sales. Toshiba release

> Two Norton Healthcare spine surgeons are being criticized by The Spine Journal for failing to mention the serious complications of Medtronic's Infuse. John Dimar II and Steven Glassman are among numerous U.S. doctors who under-reported or failed to mention the product's potential side effects--which include cancer, male sterility, unwanted bone growth and nerve damage--in Medtronic-sponsored papers published between 2000 and 2010. News

> Andrew Baker wants the government to crack down on what he calls a pattern of kickbacks in the medical testing business. He maintains the alleged scheme costs taxpayers hundreds of millions of dollars a year. Baker has laid out his accusations in a lawsuit against Quest Diagnostics, one of the largest medical testing labs in the U.S. Story

> CareFusion has completed the acquisition of Rowa, a German company specializing in robotic medication storage and retrieval systems, for about $150 million in cash. CareFusion release

And Finally... A lens-free, pinhead-size camera could grace the tip of a surgery needle or take cheap 3D images of cells. The microscopic device has no lenses or moving parts, but is instead made of 4,000 light sensors-the same thin silicon pixels used in computers and retail cameras. Article

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.